drugset / Trial / NCT01737840

Comparison of Pantoprazole and Ranitidine in Dyspepsia

NCT01737840

Phase 4 Completed 66 enrolled Akdeniz University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The H0 hypothesis of the study is there is no difference between pantoprazole and ranitidine in treating patients presented with dyspepsia to the emergency department. The H1 hypothesis is there is difference between pantoprazole and ranitidine in treating patients presented with dyspepsia to the emergency department.

Timeline

Start
2012-10
Primary completion
2013-01
Completion
2013-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Pantoprazole Other / unclassified 40 mg Intravenous
Comparator Ranitidine Unknown 50 mg Intravenous

Indications